Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Featured products

Featured products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC8809 Bedaquiline fumarate Featured
Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis.
More description
DC9964 BEC hydrochloride Featured
BEC is a boronic acid-based arginine analog that acts as a slow-binding, competitive transition state inhibitor of arginase I and II (Ki = 310 nM for human recombinant type II arginase, pH 7.5).
More description
DC10280 BD1063 dhydrochloride Featured
BD1063 dhydrochloride is a potent and selective sigma 1 receptor antagonist.
More description
DC8313 BD1047.2HBr Featured
BD 1047 dihydrobromide is a selective antagonist of σ receptors.
More description
DC10885 BCI-121 Featured
BCI-121 is a SMYD3 inhibitor that impairs the proliferation of cancer cell.
More description
DC20754 BC-1215 Featured
BC-1215 (BC1215) is a highly unique, selective E3 ligase F box component Fbxo3 inhibitor with IL1β IC50 of 0.9 ug/mL.
More description
DC8922 Bazedoxifene Featured
Bazedoxifene is a selective estrogen receptor modulator (SERM) currently in development for osteoporosis prevention and treatment.
More description
DC10526 BAY-1895344 HCl(Elimusertib) Featured
BAY-1895344 is a potent and selective ATM inhibitor. BAY 1895344 shows potent anti-tumor efficacy in monotherapy and strong combination potential with the targeted alpha therapy Radium-223 dichloride.
More description
DC9679 BAY1217389 Featured
BAY1217389 is an orally bioavailable, selective inhibitor of the serine/threonine kinase monopolar spindle 1 (Mps1, TTK), with potential antineoplastic activity.
More description
DC7996 BAY 87-2243 Featured
BAY 87-2243 is a highly potent and selective inhibitor of hypoxia-induced HIF-1 activation.
More description
DC9632 BAY 61-3606 (dihydrochloride) Featured
BAY 61-3606 2Hcl is a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (Ki= 7.5 nM) with no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src.
More description
DC9783 Bay 59-3074 Featured
Bay 59-3074 is a novel CB1/CB2 receptor partial agonist (Ki values are 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively).
More description
DC7323 Pritelivir(BAY-57-1293) Featured
BAY 57-1293 represents a new class of potent inhibitors of herpes simplex virus (HSV) that target the virus helicase primase complex.
More description
DC10085 Bay 41-4109 (racemate) Featured
BAY 41-4109 racemate is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM.
More description
DC23745 BAY-2402234 Featured
BAY 2402234 (BAY2402234) is a novel potent, selective, orally bioavailable DHODH inhibitor with IC50 of 1.2 nM (human full-length DHODH).
More description
DC8038 Bay 11-7085 Featured
BAY 11-7085 is an irreversible inhibitor of TNFα-induced IκBα phosphorylation with an IC50 value of 10 μM.
More description
DC7869 BAY11-7082 Featured
BAY 11-7082 is a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation with IC50 of 10 μM. Also inhibiting components of the ubiquitin system.
More description
DC8133 Batimastat(BB-94) Featured
Batimastat was used to study the role of MMP in proteolytic release of EGF in human follicular thyroid carcinoma cell line FTC-133.
More description
DC5064 Baricitinib (INCB28050, LY3009104) Featured
Baricitinib is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, ~70 and ~10-fold selective versus JAK3 and Tyk2, no inhibition to c-Met and Chk2,showed potent activity against COVID-19(SARS-COV-2).
More description
DC4135 Bardoxolone methyl Featured
Bardoxolone methyl (also known as “RTA 402” and “CDDO-methyl ester”) is an orally-available first-in-class synthetic triterpenoid belonging to the antioxidant inflammation modulator (AIM) class.
More description
DC10564 BAR 502 Featured
BAR502 is a dual FXR and GPBAR1 agonist with IC50 values of 2 μM and 0.4 μM, respectively.
More description
DC8298 BAN ORL 24 Featured
BAN ORL 24 is a potent, selective, competitive ORL1 non-peptide agonist. Displays 1000-fold selectivity over classical opioid receptors.
More description
DC11516 Balovaptan Featured
Balovaptan (RG7314, RG-7314) is a potent, selective vasopressin-1 receptor antagonist..
More description
DC7371 Balicatib Featured
Balicatib(AAE-581) is a potent and selective inhibitor of cathepsin K; 10-100-fold more potent in cell-based enzyme occupancy assays than against cathepsin B, L, and S.
More description
DC2013 Bafetinib (INNO-406) Featured
Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM and 19 nM, respectively.
More description
DC10026 B02 Featured
B02 is a cell-permeable pyridinylvinyl-quinazolinone compound that is shown to specifically inhibit human RAD51 (IC50 = 27.4 µM).
More description
DC8338 Azeliragon(PF-04494700,TTP488) Featured
Azeliragon is an oral, small-molecule inhibitor of RAGE.
More description
DC9268 AZD9496 Featured
AZD9496 is a potent and orally bioavailable selective estrogen receptor downregulator(Ki=0.7 nM) and antagonist.
More description
DC7006 AZD-9291(Osimertinib) Featured
AZD-9291 is a potent and selective mutated forms EGFR inhibitor(Exon 19 deletion EGFR IC50=12.92 nM, L858R/T790M EGFR IC50= 11.44 nM, wild type EGFR IC50= 493.8 nM).
More description
DC9879 AZD8835 Featured
AZD8835 ia a novel mixed inhibitor of PI3Kα and PI3Kδ with IC50 of 6.2 nM and 5.7 nM, respectively, also with selectivity against PI3Kβ (IC50=431 nM) and PI3Kγ (IC50=90 nM).
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X